Settore

Anticancer therapy

5 bandi attivi in questo settore.

European Partnership on Rare Diseases (ERDERA) (Phase 2)

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing dise…

15 set 2026

EU Funding Aperto

Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

Commissione Europea

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes: Patient…

15 set 2026

EU Funding Aperto

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

Commissione Europea

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: Patien…

21 set 2027

EU Funding Aperto

Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

Commissione Europea

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: Patien…

21 set 2027

EU Funding Aperto

Leveraging functional genomics to reveal novel targets for cancer treatment

Commissione Europea

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes: Researc…

21 set 2027